What is the price target for SMG stock?
11 analysts have analysed SMG and the average price target is 77.93 USD. This implies a price increase of 18% is expected in the next year compared to the current price of 66.04.
NYSE:SMG • US8101861065
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCOTTS MIRACLE-GRO CO (SMG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-26 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-03-03 | Stifel | Maintains | Buy -> Buy |
| 2026-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Stifel | Upgrade | Hold -> Buy |
| 2025-11-05 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Stifel | Maintains | Hold -> Hold |
| 2025-07-31 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-09 | Stifel | Downgrade | Buy -> Hold |
| 2025-06-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-06 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-01 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-07 | Jefferies | Upgrade | Hold -> Buy |
| 2025-04-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.551B -9.50% | 3.553B 0.04% | 3.413B -3.93% | 3.344B -2.02% | 3.432B 2.63% | 3.528B 2.80% | 3.728B 5.67% | 3.886B 4.24% | 3.903B 0.44% | 4.035B 3.38% | 4.17B 3.35% | |
| EBITDA YoY % growth | 384.3M -26.72% | 435.7M 13.37% | 517.3M 18.73% | 602.23M 16.42% | 643.29M 6.82% | 688.7M 7.06% | 743.76M 7.99% | 790.98M 6.35% | 792.55M 0.20% | 840.42M 6.04% | 890.42M 5.95% | |
| EBIT YoY % growth | 291.8M -30.39% | 355.1M 21.69% | 442.3M 24.56% | 486.33M 9.95% | 524.99M 7.95% | 565.77M 7.77% | 593.48M 4.90% | 635.69M 7.11% | 607.11M -4.50% | 648.72M 6.85% | 692.25M 6.71% | |
| Operating Margin | 8.22% | 10.00% | 12.96% | 14.54% | 15.30% | 16.04% | 15.92% | 16.36% | 15.55% | 16.08% | 16.60% | |
| EPS YoY % growth | 1.16 -71.64% | 2.24 93.10% | 3.72 66.07% | 4.34 16.70% | 4.89 12.55% | 5.44 11.27% | 6.48 19.17% | 7.26 12.00% | 7.42 2.30% | 8.35 12.52% | 9.35 11.97% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.05 1.73% | 2.86 10.50% | -1.81 7.47% | -0.70 9.34% | 4.38 8.25% | 3.05 6.40% | -1.67 7.66% | -0.62 10.83% | 4.72 7.76% | 3.25 6.83% | -1.60 4.68% |
| Revenue Q2Q % growth | 1.42B -0.07% | 1.222B 2.86% | 348.28M -10.10% | 367.32M 3.65% | 1.46B 2.82% | 1.261B 3.19% | 357.81M 2.74% | 379.43M 3.30% | 1.508B 3.29% | 1.305B 3.49% | 370.68M 3.60% |
| EBITDA Q2Q % growth | 401.88M 0.32% | 280.38M 1.00% | -83.84M -125.98% | -479.75K -59.92% | 432.2M 7.54% | 298.28M 6.38% | -66.382M 20.82% | -555.5K -15.79% | 457.48M 5.85% | 322.95M 8.27% | -79.437M -19.67% |
| EBIT Q2Q % growth | 369.03M 1.75% | 244.08M 10.39% | -108.19M 3.49% | -18.402M 1.59% | 400.25M 8.46% | 262.94M 7.73% | -99.94M 7.63% | -16.19M 12.02% | 416.18M 3.98% | 275.58M 4.81% | -96.97M 2.97% |
All data in USD
11 analysts have analysed SMG and the average price target is 77.93 USD. This implies a price increase of 18% is expected in the next year compared to the current price of 66.04.
SCOTTS MIRACLE-GRO CO (SMG) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of SCOTTS MIRACLE-GRO CO (SMG) is 4.05 USD and the consensus revenue estimate is 1.42B USD.
The consensus rating for SCOTTS MIRACLE-GRO CO (SMG) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.